We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Pocket Colposcope Promises Easier Cancer Screening

By HospiMedica International staff writers
Posted on 30 Jun 2017
Print article
Image: Research asserts a prototype mini colposcope can make cervical cancer screening more accessible (Photo courtesy of Duke University).
Image: Research asserts a prototype mini colposcope can make cervical cancer screening more accessible (Photo courtesy of Duke University).
A novel handheld device could replace uncomfortable speculums and high-cost colposcopes used for cervical cancer screening.

Developed by researchers at Duke University (Durham NC, USA), the POCkeT colposcope is a miniature, tampon-sized vaginal inserter with a slim tubular body that has a funnel-like curved tip measuring approximately 2.5 cm in diameter. The inserter has a channel through which a two megapixel mini camera with light emitting diode (LED) illumination fits in in order to capture an image. The device also includes a channel through which contrast agents, such as acetic acid or Lugol’s iodine, can be used so that cervical cancer screening procedures can be applied.

The POCkeT colposcope, which was developed using 3D computer-aided design (CAD) software, was tested using mechanical simulations on a custom vaginal phantom model, employing a range of vaginal pressures and uterine tilts in order to finalize the optimal design. Two final designs were tested with fifteen volunteers to assess cervix visualization, comfort, and usability, as compared to a standard metal speculum. The POCkeT colposcope can also connect to other devices, including laptops or cell phones. The study describing the design process and testing were published on May 31, 2017, in PLOS One.

“The mortality rate of cervical cancer should absolutely be zero percent because we have all the tools to see and treat it; but it isn’t,” said senior author professor of biomedical engineering Nimmi Ramanujam, PhD. “That is in part because women do not receive screening or do not follow up on a positive screening to have colposcopy performed at a referral clinic. We need to bring colposcopy to women so that we can reduce this complicated string of actions into a single touch point.”

Cervical cancer is the fourth most common cancer in women, with more than 500,000 new cases occurring annually worldwide. The two most common detection methods include the Pap smear, which can be performed by a non-specialist, and colposcopy, which requires visualization of the cervix using a speculum, a colposcope, and a trained professional to administer the test. Colposcopes and people who know how to use them are difficult to find in many low-income regions.

Related Links:
Duke University

Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Oxidized Zirconium Implant Material
OXINIUM

Print article

Channels

Surgical Techniques

view channel
Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more